FMP
SNDL Inc.
SNDL
NASDAQ
SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Cannabis Operations and Retail Operations segments. It engages in the cultivation, distribution, and sale of cannabis for the adult-use markets; and private sale of recreational cannabis through corporate owned and franchised retail cannabis stores. The company also produces and distributes inhalable products, such as flower, pre-rolls, and vapes. It offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. The company was formerly known as Sundial Growers Inc. and changed its name to SNDL Inc. in July 2022. SNDL Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.
1.8 USD
0.07 (3.89%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Mr. Zachary Ryan George IV
sector
Healthcare
industry
Drug Manufacturers - Specialty & Generic
website
https://www.sndlgroup.comexchange
NASDAQ
Description
SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Cannabis Operations and Retail Operations segments. It engages in the cultivation, distribution, and sale of cannabis for the adult-use markets; and private sale of recreational cannabis through corporate owned and franchised retail cannabis stores. The company also produces and distributes inhalable products, such as flower, pre-rolls, and vapes. It offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. The company was formerly known as Sundial Growers Inc. and changed its name to SNDL Inc. in July 2022. SNDL Inc. was incorporated in 20...
CIK
0001766600
ISIN
CA83307B1013
CUSIP
86730L109
Address
919–11 Avenue SW
Phone
14039485227
Country
CA
Employee
2,516
IPO Date
Aug 1, 2019
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
SNDL Financial Summary
CIK
0001766600
Exchange
NASDAQ
Industry
Drug Manufacturers -...
Sector
Healthcare
CUSIP
86730L109
ISIN
CA83307B1013
Country
CA
Price
1.8
Beta
3.2
Volume Avg.
2.15M
Market Cap
477.9M
Shares
-
52-Week
1.3-2.93
DCF
0
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-6
P/B
-
Website
https://www.sndlgroup.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest SNDL News
It looks like there's no news available.
